President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs ...

Who Will Have RA Flares on a Lower Dose Following Remission? Reducing the dose of biologic drugs may not match standard treatment in preventing disease flares at 1 year in patients with rheumatoid ...

New guidelines recommend considering cholesterol-lowering statins in the 30s, screening all adults for hidden risk factors ...

A retrospective cohort study found that beta-blocker use is associated with a decreased risk for incident HF in certain SAID populations.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus, and other devastating autoimmune diseases – by reprogramming patients’ out-of-whack immune ...

Chronic fatigue or joint pain? It could be autoimmune. Learn how to get tested and what new biologic drugs could mean for treatment.

From endometriosis and cervical cancer, to diabetes, vitamin D deficiency and pollution exposure, scientists are finding ...

At 11 years old, Mykela Shields has experienced more hospital stays, tests and procedures than most people will in their lifetime. Her memories consist of the pinch of a blood draw, the ...

Navigating drug coverage demands brain power in our DIY retirement system, and it isn’t getting any easier. While President Donald Trump has launched TrumpRx and other initiatives to lower costs, ...

Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Connor Hill, 17, of State College, Pennsylvania, won the top award of $250,000 in the 2026 Regeneron Science Talent ...

Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Connor Hill , 17, of State College, Pennsylvania , won the top award of $250,000 in the 2026 Regeneron Science ...

He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...